- Neuroscience, including: Alzheimer's disease, epilepsy, pain and weight
loss
- Oncology including: anticancer therapies; tumour regression, tumour
suppression, antibodies, etc.
- Vascular/Immunological reaction including: thrombocytopenia, rheumatoid
arthritis, psoriasis, inflammatory bowel disease
With operations in the U.S., Asia, Europe and its domestic home market of Japan, Eisai employs more than 10,000 people worldwide. From its EMEA Knowledge Centre in Hatfield, UK, Eisai has recently expanded its business operations to include Europe, the Middle East, Africa, Russia and Oceania (EMEA). Eisai EMEA has sales and marketing operations in over 20 markets, including the United Kingdom, France, Germany, Italy, Spain, Switzerland, Sweden, Ireland, Austria, Denmark, Finland, Norway, Portugal, Czech Republic, Slovakia, the Netherlands, Belgium, Russia and the Middle East.
For further information please visit our web site http://www.eisai.co.uk
References
1. WHO Preventive Chemotherapy and Transmission Control (PCT) Databank (as of 2012) http://www.who.int/neglected_diseases/pr... [Last accessed October 2013] 2. WHO. Lymphatic filariasis Factsheet. March 2013. http://www.who.int/mediacentre/factsheet... [http://www.who.int/mediacentre/factsheet... ]# [Last accessed October 2013] 3. WHO. The 17 neglected tropical diseases. http://www.who.int/neglected_diseases/di... [http://www.who.int/neglected_diseases/di... ] [Last accessed October 2013] 4. World Bank. Poverty Overview. http://www.worldbank.org/en/topic/povert... [Last accessed October 2013]
Date of preparation: October 2013
Job code: corporate-UK2019
CONTACT: Media Enquiries: Eisai Europe Ltd, Cressida Robson / CharlotteAndrews, +44(0)7908-314-155/ +44(0)7947-231-513, Cressida_Robson@eisai.net,Charlotte_Andrews@eisai.net; Tonic Life Communications, SiobhanReilly/Frances Murphy, +44(0)790-060-5652/+44(0)207-798-9900,Siobhan.Reilly@toniclc.com, Frances.Murphy@toniclc.com
